Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2007 2
2008 2
2009 2
2010 2
2011 4
2012 3
2013 3
2014 5
2015 1
2016 7
2017 10
2018 9
2019 9
2020 24
2021 25
2022 33
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
The Polypharmacological Effects of Cannabidiol.
Castillo-Arellano J, Canseco-Alba A, Cutler SJ, León F. Castillo-Arellano J, et al. Molecules. 2023 Apr 6;28(7):3271. doi: 10.3390/molecules28073271. Molecules. 2023. PMID: 37050032 Free PMC article. Review.
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). ...In this article, a rationalized integration of the mechanisms of action of CBD on molecular targets and pharmacological implications in animal models and human diseases, such as epi …
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). ...In this article, a rationalized integrati …
Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M. Bhunia S, et al. Front Pharmacol. 2022 Oct 25;13:989717. doi: 10.3389/fphar.2022.989717. eCollection 2022. Front Pharmacol. 2022. PMID: 36386183 Free PMC article. Review.
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endocannabinoid system as a molecular target in the central nervous system (CNS). Cannabidiol (CBD), the major non-psychoactive component of …
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endocan …
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C. Li H, et al. Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22. Eur J Med Chem. 2020. PMID: 32109623 Review.
Furthermore, CBD prevents the glycogen synthase kinase 3beta (GSK-3beta) hyperphosphorylation caused by Abeta and may be developed as a new therapeutic candidate for Alzheimer's disease....
Furthermore, CBD prevents the glycogen synthase kinase 3beta (GSK-3beta) hyperphosphorylation caused by Abeta and may be developed as a new …
Phytochemistry of Cannabis sativa L.
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. ElSohly MA, et al. Prog Chem Org Nat Prod. 2017;103:1-36. doi: 10.1007/978-3-319-45541-9_1. Prog Chem Org Nat Prod. 2017. PMID: 28120229 Review.
Besides delta(9)-THC, there are also non-psychoactive cannabinoids with several medicinal functions, such as cannabidiol (CBD), cannabichromene (CBC), and cannabigerol (CBG), along with other non-cannabinoid constituents belonging to diverse classes of natural products. .. …
Besides delta(9)-THC, there are also non-psychoactive cannabinoids with several medicinal functions, such as cannabidiol (CBD), canna …
Cannabinoids for the treatment of dementia.
Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L. Bosnjak Kuharic D, et al. Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2. Cochrane Database Syst Rev. 2021. PMID: 34532852 Free PMC article. Review.
SEARCH METHODS: We searched ALOIS - the Cochrane Dementia and Cognitive Improvement Group's Specialised Register - on 8 July 2021, using the terms cannabis or cannabinoid or endocannabinoid or cannabidiol or THC or CBD or dronabinol or delta-9-tetrahydrocannabinol or marij …
SEARCH METHODS: We searched ALOIS - the Cochrane Dementia and Cognitive Improvement Group's Specialised Register - on 8 July 2021, using the …
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.
Watt G, Karl T. Watt G, et al. Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. eCollection 2017. Front Pharmacol. 2017. PMID: 28217094 Free PMC article. Review.
Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of people. ...Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has demonstrated neuroprotective, anti-inflammatory and antio …
Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of p …
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L, Bisogno T, Di Marzo V. Cristino L, et al. Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12. Nat Rev Neurol. 2020. PMID: 31831863 Review.
The approvals of nabiximols, a mixture of THC and the non-psychotropic cannabinoid cannabidiol, for the treatment of spasticity and neuropathic pain in multiple sclerosis, and of purified botanical cannabidiol for the treatment of otherwise untreatable forms of paed …
The approvals of nabiximols, a mixture of THC and the non-psychotropic cannabinoid cannabidiol, for the treatment of spasticity and n …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease and multiple sclerosis, as well as anorexia and irritable bow …
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's dise …
Cannabidiol goes nuclear: The role of PPARgamma.
Khosropoor S, Alavi MS, Etemad L, Roohbakhsh A. Khosropoor S, et al. Phytomedicine. 2023 Jun;114:154771. doi: 10.1016/j.phymed.2023.154771. Epub 2023 Mar 15. Phytomedicine. 2023. PMID: 36965374 Review.
METHODS: In this comprehensive literature review, the term 'cannabidiol' was used in combination with the following keywords including 'PPARgamma', 'Alzheimer's disease', 'Parkinson's disease', 'seizure', 'multiple sclerosis', 'immune system', ' …
METHODS: In this comprehensive literature review, the term 'cannabidiol' was used in combination with the following keywords includin …
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA. Singh K, et al. Behav Neurol. 2023 Oct 12;2023:8825358. doi: 10.1155/2023/8825358. eCollection 2023. Behav Neurol. 2023. PMID: 37868743 Free PMC article. Review.
Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its potential therapeutic applications. This thorough analysis explores the increasing significance of CBD in treating neurological conditions including epilepsy, multiple sclerosis, Parki …
Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its potential therapeutic applications. This tho …
160 results